Gilead Sciences GILD
NASDAQ GILD
$146.15 +2.71 (+1.89%)
As of: Aug 21, 2026 · 3:59 PM EDT

Gilead Sciences (GILD) EBITDA Margin (QoQ) (2009 - 2026)

Gilead Sciences (GILD) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 -17,036.00
Mar 31, 2026 1,212.00
Dec 31, 2025 -1,779.00
Sep 30, 2025 789.00
Jun 30, 2025 138.00
Mar 31, 2025 116.00
Dec 31, 2024 2,063.00
Sep 30, 2024 -2,625.00
Jun 30, 2024 10,266.00
Mar 31, 2024 -8,730.00
Dec 31, 2023 -1,454.00
Sep 30, 2023 1,197.00
Jun 30, 2023 -161.00
Mar 31, 2023 -384.00
Dec 31, 2022 -961.00
Sep 30, 2022 787.00
Jun 30, 2022 2,942.00
Mar 31, 2022 -999.00
Dec 31, 2021 -3,880.00
Sep 30, 2021 1,565.00